Skip to content

Catheter management bij symptomatische urineretentie na de bevalling.

Catheter Management and complications for Symptomatic Postpartum Urinary Retention.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27775
Enrollment
84
Registered
2011-03-14
Start date
2011-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary retention postpartum period catheter retention urinary kraamtijd urine retentie niet kunnen plassen catheter

Interventions

Randomization between indwelling catheterization and intermittent catheterization.

Sponsors

Academic Medical Center, Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women who deliver in the participating hospitals; 2. Vaginally and by caesarean section; 3. 18 years and older; 4. Are unable to void within 6 hours postpartum.

Exclusion criteria

Exclusion criteria: 1. Age < 18 years; 2. Insufficient knowledge or understanding of the Dutch language; 3. Congenital urinary tract abnormalities; 4. Pre-existent and treated urinary tract infection < 1 week before the delivery; 5. Patients with an indwelling catheter before delivery for parturition related reasons; 6. History of chronic neurological disease, including diabetic neuropathy.

Design outcomes

Primary

MeasureTime frame
Bladder related quality of life three months after randomization for symptomatic PUR (UDI-6 questionnaire)

Secondary

MeasureTime frame
1. Development of a risk profile for overt postpartum urinary retention; 2. Prevalence of overt postpartum urinary retention (bladderscan); 3. The prevalence of clinical urinary tract infections due to different catheterization methods; 4. Cost effectiveness analysis for different treatments of overt PUR; 5. Patient preference for different methods of catheterization.

Contacts

Public ContactFemke Mulder

Academisch Medisch Centrum Meibergdreef 9 - H4 205

f.e.mulder@amc.uva.nl+31 (0)20 5663453

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)